retatrutide latest trial results Weight Loss Results:Trial Data and FDA Status Retatrutide Phase 2 vs Phase

Sun Pharmaceutical Industries Ltd

Thanks to biochemical engineering, the glucagon-like peptide-1 (GLP-1) molecule has emerged as an

Truveta Research tracks GLP-1 RA prescribing through March 2026, showing accelerated anti-obesity use and a sharp rise in first-time semaglutide prescribing.

Indian pharma companies are betting on Chinese partnerships to bring oral GLP-1 drugs to market, but the window to act is narrower, and stakes higher

In spring 2025, the Food and Drug Administration (FDA) resolved and ended the GLP-1 medications shortage, subsequently releasing declaratory orders that neither outsourcing compounding pharmacies or pharmacies could compound drugs that were essentially copies of either semaglutide (available under the brand names Ozempic, Rybelsus, and Wegovy) and tirzepatide (available under the brand names Mounjaro, and Zepbound).